BMC Infectious Diseases

official impact factor 2.83
Search for
Advanced search
BMC Infectious Diseases
Tools
Share this article
Open Access Research article

Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort

Carlo Torti*, Giuseppe Lapadula, Salvatore Casari, Massimo Puoti, Mark Nelson, Eugenia Quiros-Roldan, Daniele Bella, Giuseppe Pastore, Nicoletta Ladisa, Lorenzo Minoli, Giovanni Sotgiu, Francesco Mazzotta, Sergio Lo Caputo, Giovanni Di Perri, Gaetano Filice, Carmine Tinelli, Giampiero Carosi and the EPOKA-MASTER Study Group

BMC Infectious Diseases 2005, 5:58 doi:10.1186/1471-2334-5-58

No comments have yet been made on this article.

Post a comment